{
    "clinical_study": {
        "@rank": "154538", 
        "arm_group": {
            "arm_group_label": "Cardiac transplant recipients"
        }, 
        "biospec_descr": {
            "textblock": "Buccal cell and blood sample for genomic DNA"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Kidney disease is a common problem after heart transplantation.  It may be caused by\n      anti-rejection medications such as cyclosporine or tacrolimus.  However, the reason why some\n      people develop kidney problems after a heart transplant, but other people do not, is not\n      fully known. This study plans to learn more about the relationship between a person's\n      genetic make-up (DNA) and the risk of kidney problems after a heart transplant. The\n      long-term goal of this research is to identify genetic variations that may help predict the\n      development of kidney problems after heart transplantation."
        }, 
        "brief_title": "Genetic Predictors of Renal Dysfunction Following Heart Transplantation", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Heart Transplantation", 
            "Chronic Renal Insufficiency"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Kidney Failure, Chronic", 
                "Renal Insufficiency, Chronic", 
                "Renal Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  cardiac-only transplant\n\n          -  18 years of age or older at the time of cardiac transplant\n\n          -  1 year or more post-cardiac transplant\n\n          -  treatment with cyclosporine or tacrolimus following transplant\n\n        Exclusion Criteria:\n\n          -  combined organ transplant\n\n          -  decisionally impaired\n\n          -  unable to read or speak English\n\n          -  unable or unwilling to provide written informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Cardiac transplant clinic"
            }
        }, 
        "enrollment": {
            "#text": "195", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01686191", 
            "org_study_id": "12-0869", 
            "secondary_id": "12GRNT12040211"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "heart transplantation", 
            "chronic renal insufficiency", 
            "pharmacogenomics", 
            "cyclosporine", 
            "tacrolimus"
        ], 
        "lastchanged_date": "December 9, 2013", 
        "location": {
            "contact": {
                "email": "christina.aquilante@ucdenver.edu", 
                "last_name": "Christina L Aquilante, Pharm.D.", 
                "phone": "303-724-6126"
            }, 
            "facility": {
                "address": {
                    "city": "Aurora", 
                    "country": "United States", 
                    "state": "Colorado", 
                    "zip": "80045"
                }, 
                "name": "University of Colorado Anschutz Medical Campus"
            }, 
            "investigator": [
                {
                    "last_name": "Christina L Aquilante, Pharm.D.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "JoAnn Lindenfeld, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Robert L Page, Pharm.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Pharmacogenomics of Calcineurin Inhibitor Nephrotoxicity in Cardiac Transplantation", 
        "overall_contact": {
            "email": "christina.aquilante@ucdenver.edu", 
            "last_name": "Christina L Aquilante, Pharm.D.", 
            "phone": "303-724-6126"
        }, 
        "overall_official": {
            "affiliation": "University of Colorado, Denver", 
            "last_name": "Christina L Aquilante, Pharm.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Chronic renal dysfunction", 
            "safety_issue": "No", 
            "time_frame": "year 2 post-transplant"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01686191"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Colorado, Denver", 
        "sponsors": {
            "collaborator": {
                "agency": "National Jewish Health", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Colorado, Denver", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}